Gradient Denervation Technologies
French tech company | Builders Republic
About
Medical device company developing a minimally invasive catheter system for pulmonary hypertension — using therapeutic ultrasound energy to ablate nerves around the pulmonary artery (pulmonary artery denervation), targeting Group 2 pulmonary hypertension patients with no approved drug or device therapy, under FDA Breakthrough Designation.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2019
- City
- SURESNES
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 3.5 M€ raised since 2020
Funding rounds
- Series A — 2020